Herbal Medicine Market Size, Revenue Growth Trends, Company Strategy Analysis Till 2027

 

The Herbal Medicine market is estimated to be valued at USD 1,29,689.3 million by 2023 and expected to grow at a CAGR of 5.88% during the forecast period. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the herbal medicine market. The hospital & retail pharmacies segment accounted for the largest market share of 55.82% in 2017.

Various government organizations such as the National Institutes of Health (NIH) have increased the spending on the research of medicinal applications of various plants for the treatment of various chronic diseases such as cancer, arthritis, and many more. According to the National Centre for Biotechnology Information, the National Institutes of Health (NIH) spent USD 111,275,219 on all cannabinoid research in 2015. The increasing acceptance of herbal medicines globally and raising funds for their development are likely to support market growth.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3250

Herbal medicines are used since ancient times for numerous health conditions. It is the oldest and most extensively used system of medicine in the world today. There are various kinds of herbal medicines and supplements used across the world. According to the National Center for Biotechnology Information, 2015, the World Health Organization (WTO), reported that around 70% to 80% of people globally rely on herbal sources for their treatment. Also, according to the American Botanical Council, September 2017, it was reported that in 2016, the sale of herbal supplements increased by 7.7% in the US. It was also estimated that consumers spending on herbal supplements increased to USD 7.452 billion in 2016. Thus, the increase in the demand for herbal products for healthcare purposes is likely to enhance this market during the forecast period. 

However, along with multiple applications, herbal medicines have some side-effects and allergic reactions such as dizziness, dry mouth, itching, erythematous lesions, and others. In some cases, they may cause kidney failure and liver damage to the patient. According to the National Center for Biotechnology Information 2017, 59.8% of people suffered from rash erythematous and 8.4% from allergic reactions after the use of herbal medicines. Also, according to the National Kidney Foundation 2017, herbal medicines are unsafe for patients having kidney problems because the kidney may not function properly and may create other complications after the consumption of herbal medicines. Thus, allergic reactions and adverse effects after the use of herbal medicines may affect market growth.

Segment analysis

Global herbal medicine market has been segmented on the basis of category, source, form, distribution channel, and region. On the basis of category, the market is divided into herbal pharmaceuticals, herbal dietary supplements, herbal functional foods, and herbal beauty products. The herbal pharmaceutical segment is growing owing to the increasing research and development on various herbs to find their medicinal properties, growing demand for natural medicines having fewer side-effects, and rising prevalence of chronic diseases such as diabetes, arthritis, cancer, sleep disorders, and digestive problems.

On the basis of form, the market has been divided into extracts, powders, capsules and tablets, syrups, and others.

On the basis of distribution channel, is segmented into hospital and retail pharmacies, e-commerce, and others. The hospital & retail pharmacies segment accounted for the largest market share in 2017. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the herbal medicine market.

Regional Analysis

Geographically, the global herbal medicine market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Americas accounts for the second largest share in the global Herbal Medicine market. It accounted for a considerable market share of 16.2% as of 2017. The use of herbal medicines is also growing in the US after conducting the first national study of alternative and complementary medicines used by Eisenberg et al. According to the National Center for Biotechnology Information 2017, it was reported that herbal supplements were majorly used for conditions such as cancer (43.1%), stroke (48.7%), and arthritis (43%) in the US. Such a high demand and preference for herbal products is likely to boost the market growth during the forecast period.

Europe is expected to account for the largest market share owing to extensive R&D for herbal medicine, increasing funding for research on medicinal plants, and growing preference for herbal drugs globally. On a regional basis, Europe is segmented into Western Europe and Eastern Europe. Western Europe is estimated to lead market growth during the forecast period. The increasing prevalence of chronic diseases and rising government support facilitate market growth within the region.

Asia-Pacific is expected to register a CAGR of 5.99% during the forecast period owing to the adoption of traditional medicines by pharmaceutical companies, researchers, and policymakers. On the other hand, the Middle East and Africa is expected to observe a slow growth due to less awareness and in-depth knowledge about herbal drugs in this region.

Key Findings of the Study:

  • Asia Pacific is estimated to be the fastest growing market during the forecast period due to rising geriatric population and extensive use of healthcare IT
  • Marrubium vulgare is the dominant type of medicinal plants for Herbal Medicine market across all regional segments during the forecast period due to the increasing applications of Marrubium vulgare.
  • The hospital & retail pharmacies segment accounted for the largest market share in the distribution channel segment owing to the growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals.
  • Herbal pharmaceutical accounted for the largest market share of 55.18% in 2017. The herbal pharmaceutical segment is growing owing to the increasing research and development on various herbs to find their medicinal properties, growing demand for natural medicines having fewer side-effects, and rising prevalence of chronic diseases such as diabetes, arthritis, cancer, sleep disorders, and digestive problems.
  • Some of the players operating in the Herbal Medicine market are Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp, and Arizona Natural Products among other.

Report Details @ https://www.marketresearchfuture.com/reports/herbal-medicine-market-3250

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

hematuria treatment market

Orthopedic Trauma Devices Market

Chronic Disease Management Market

Middle East and Africa Surgical Sutures Market

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Comments

Post a Comment

Popular posts from this blog

Digital Pathology Market Research, Size, Revenue, Trends, Competitive Landscape Study & Analysis, Forecast To 2028

Image
  The growing number of innovations in the areas of pathology would further increase the size of the market to a great deal, in the next six years. According to MRFR, the Digital Pathology Market is expected to register a CAGR of 6.5% over the review period from 2021 to 2028 and expected to reach USD 1.4 Billion by 2028. Digital Pathology or Computational Pathology leverages completely new perceptions through data analysis, enabling pathologists to consult on treatment options. The rapidly evolving pathology sector is a key element of modern diagnostic practices. There have been several innovations and widespread adoption of digital pathology. It has long been realized that the traditional histopathology is inefficient as it exposes samples to various handlers, increasing the scope for human error. The digital pathology, on the other hand, eliminates the risk factors, while also providing the pathologist with the necessary images and clinical information to generate the most a...
Read more

Structural Heart Devices Market Size, Key Player Revenue, SWOT, PEST & Porter’s Analysis Till 2027

Image
Structural heart diseases   are problems associated with the valves or tissues of the heart. These diseases may be congenital or might be acquired later in life. Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others. As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period. The  structural heart devices market  is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to pro...
Read more

Anal Fissure Treatment Market Competitive Landscape, Growth Factors, Revenue Analysis Till 2030

Image
  The global  anal fissure treatment market  is expected to rise and touch a valuation of USD 2,526.5 million by 2023, at a 7.6% CAGR during the forecast period. Anal fissures are small tears near the mucosal lining of the anus. Deeper cuts may take a combination of oral and topical medicine to alleviate the pain. The anal fissure treatment market is expected to thrive owing to the booming pediatric and geriatric patient pool. Advances in technology coupled with various treatment options is likely to lead to a windfall for the market over the forecast period. High incidence of constipation is predicted to drive the need for anal fissure treatments. This is backed by vulnerability of the elderly which find it difficult to pass stools properly. According to the American Gastroenterological, nearly 33% of Americans above 60 experience the condition. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3841 Unhealthy lifestyles adopted by pat...
Read more